1. Abdulkhaliq AA, Kim B, Almoghrabi YM, Khan J, Ajoolabady A, Ren J, et al. Amyloid-β and Tau in Alzheimer's disease: pathogenesis, mechanisms, and interplay. 2026; 17(1) :21. [DOI:10.1038/s41419-025-08186-8]

2. Yaghoubi A. Changes in Aβ42, Neprilysin, and γ-Secretase in the Hippocampus of Male Rats Alzheimer's model: The Effects of Aerobic Training and Omega-3 Intake %J Journal of Kerman University of Medical Sciences. 2023; 30(3): 136-45. [DOI:10.34172/jkmu.2023.23]

3. Iqbal K, Liu F, Gong C-XJNrn. Tau and neurodegenerative disease: the story so far. 2016; 12(1): 15-27. [DOI:10.1038/nrneurol.2015.225]

4. Zhang X, Wang J, Zhang Z, Ye KJTN. Tau in neurodegenerative diseases: molecular mechanisms, biomarkers, and therapeutic strategies. 2024; 13(1): 40. [DOI:10.1186/s40035-024-00429-6]

5. Serrano-Pozo A, Frosch MP, Masliah E, Hyman BTJCSHpim. Neuropathological alterations in Alzheimer disease. 2011; 1(1): a006189. [DOI:10.1101/cshperspect.a006189]

6. Arnsten AF, Del Tredici K, Barthélemy NR, Gabitto M, van Dyck CH, Lein E, et al. An integrated view of the relationships between amyloid, tau, and inflammatory pathophysiology in Alzheimer's disease. 2025; 21(8): e70404. [DOI:10.1002/alz.70404]

7. Jahan I, Adachi R, Egawa R, Nomura H, Kuba HJJoN. CDK5/p35-dependent microtubule reorganization contributes to homeostatic shortening of the axon initial segment. 2023; 43(3): 359-72. [DOI:10.1523/JNEUROSCI.0917-22.2022]

8. Jiang T, Chang RC-C, Rosenmann H, Yu J-TJBRI. Advances in Alzheimer's disease: From bench to bedside. 2015; 2015: 202676. [DOI:10.1155/2015/202676]

9. Piedrahita D, Hernández I, López-Tobón A, Fedorov D, Obara B, Manjunath B, et al. Silencing of CDK5 reduces neurofibrillary tangles in transgenic alzheimer's mice. 2010; 30(42): 13966-76. [DOI:10.1523/JNEUROSCI.3637-10.2010]

10. Kumari S, Singh AK, Kumar M, Pradhan R, Rao AR, Yadav Y, et al. Targeting a Tau Kinase Cdk5, Cyclin-Dependent Kinase: A Blood-Based Diagnostic Marker and Therapeutic Earmark for Alzheimer's Disease. 2025; 15(10): 1365. [DOI:10.3390/biom15101365]

11. Giese KPJFimn. Generation of the Cdk5 activator p25 is a memory mechanism that is affected in early Alzheimer's disease. 2014; 7: 36. [DOI:10.3389/fnmol.2014.00036]

12. Pahlavani HAJFiAN. Exercise therapy to prevent and treat Alzheimer's disease. 2023; 15: 1243869. [DOI:10.3389/fnagi.2023.1243869]

13. Chapman SB, Aslan S, Spence JS, DeFina LF, Keebler MW, Didehbani N, et al. Shorter term aerobic exercise improves brain, cognition, and cardiovascular fitness in aging. 2013; 5: 75. [DOI:10.3389/fnagi.2013.00075]

14. Li W, Wang W-H, Song Y, Li X-J, Li Y, Wang X, et al. Mechanistic advances in exercise‑mediated regulation of autophagy dysfunction in Alzheimer's disease. 2026; 57(4): 1-16. [DOI:10.3892/ijmm.2026.5755]

15. Kang J, Liu M, Yang Q, Dang X, Li Q, Wang T, et al. Exercise training exerts beneficial effects on Alzheimer's disease through multiple signaling pathways. 2025; 17: 1558078. [DOI:10.3389/fnagi.2025.1558078]

16. Saghebjoo M, ia Fallah-Mohammadi Z, Hedayati M, Moghaddam AHJK. Effects of eight weeks aerobic training on levels of amyloid β42, neprilysin and γ-secretase in the hippocampus of male rat Alzheimer's model by homocysteine injection. 2016; 17(4): 996-1005.

17. Mattson MPJCm. Energy intake and exercise as determinants of brain health and vulnerability to injury and disease. 2012; 16(6): 706-22. [DOI:10.1016/j.cmet.2012.08.012]

18. Sampaio A, Marques EA, Mota J, Carvalho JJD. Effects of a multicomponent exercise program in institutionalized elders with Alzheimer's disease. 2019; 18(2): 417-31. [DOI:10.1177/1471301216674558]

19. Moreira-Silva D, Vizin RC, Martins TM, Ferreira TL, Almeida MC, Carrettiero DCJB-p. Intracerebral injection of streptozotocin to model Alzheimer disease in rats. 2019; 9(20): e3397-e. [DOI:10.21769/BioProtoc.3397]

20. Yaghoubi AJJoKUoMS. Changes in Aβ42, Neprilysin, and γ-Secretase in the Hippocampus of Male Rats Alzheimer's model: The Effects of Aerobic Training and Omega-3 Intake. 2023; 30(3): 136-45. [DOI:10.34172/jkmu.2023.23]

21. Azarniveh MS, Vahdatpoor H, Khademosharie M, Balaghi Inaloo F, Taheri AJAoASS. The effect of eight weeks of High-Intensity interval training on plasma LRP1, AB1-42, and insulin resistance in obese elderly diabetic rats. 2024; 12(4).

22. Mohammadzadeh E, Alipour F, Khallaghi B. Evaluation of Spatial Memory Impairment after Intracerebroventricular Streptozocin Injection in Adult Rats. The Neuroscience Journal of Shefaye Khatam. 2014; 2(1): 40-5. [DOI:10.18869/acadpub.shefa.2.1.40]

23. Pasand Mozhdeh H, Zeynali HA, Iraj Kashani Radgerdi, Sahab Negah s, Hassanzadeh G. The Effect of Intracerebroventricular Administration of Streptozocin on Cell Proliferation in Subventricular Zone Stem Cells in a Rat Model of Alzheimer's Disease. The Neuroscience Journal of Shefaye Khatam. 2015; 3(4): 80-5. [DOI:10.18869/acadpub.shefa.3.4.80]

24. Kazemi A, Rahmati M, MONTAZER S. The effect of decreased activity in the form of spinal cord ligation on cdk5 expression in sciatic nerve and behavioral test of wistar male rats with neuropathic pain. 2016.

25. Wang Y, Sheng H, Zhao J, Guo L, Liu J, Xu J, et al. Changes in the prefrontal cortex after the hippocampus was injected with Aβ25-35 via the P35/P25-CDK5-Tau hyperphosphorylation signaling pathway. 2021; 741: 135453. [DOI:10.1016/j.neulet.2020.135453]

26. Huang Y, Huang W, Huang Y, Song P, Zhang M, Zhang H-T, et al. Cdk5 inhibitory peptide prevents loss of neurons and alleviates behavioral changes in p25 transgenic mice. 2020; 74(4): 1231-42. [DOI:10.3233/JAD-191098]

27. Bayod S, Del Valle J, Canudas AM, Lalanza JF, Sanchez-Roigé S, Camins A, et al. Long-term treadmill exercise induces neuroprotective molecular changes in rat brain. Journal of Applied Physiology. 2011; 111(5): 1380-90. [DOI:10.1152/japplphysiol.00425.2011]

28. Um H-S, Kang E-B, Koo J-H, Kim H-T, Kim E-J, Yang C-H, et al. Treadmill exercise represses neuronal cell death in an aged transgenic mouse model of Alzheimer's disease. Neuroscience research. 2011; 69(2): 161-73. [DOI:10.1016/j.neures.2010.10.004]

29. Ohia-Nwoko O, Montazari S, Lau Y-S, Eriksen JL. Long-term treadmill exercise attenuates tau pathology in P301S tau transgenic mice. Molecular neurodegeneration. 2014; 9(1): 1-17. [DOI:10.1186/1750-1326-9-54]

30. Norton S, Matthews FE, Barnes DE, Yaffe K, Brayne C. Potential for primary prevention of Alzheimer's disease: an analysis of population-based data. The Lancet Neurology. 2014; 13(8): 788-94. [DOI:10.1016/S1474-4422(14)70136-X]

31. Engmann O, Hortobágyi, T., Thompson, A. J., Guadagno, J., Troakes, C., Soriano, S., AlSarraj, S., Kim, Y., & Giese, K. P. . Cyclindependent kinase 5 activator p25 is generated during memory formation and is reduced at an early stage in Alzheimer's disease. Biological Psychiatry. 2011; 70(2): 10. [DOI:10.1016/j.biopsych.2011.04.011]

32. Liu Y, Chu, J.M.T., Yan, T., et al. . Short-term resistance exercise inhibits neuroinflammation and attenuates neuropathological changes in 3xTg Alzheimer's disease mice. Journal of Neuroinflammation. 2017; 17(1): 1-15. [DOI:10.1186/s12974-019-1653-7]

33. García-Mesa Y, López-Ramos, J.C., Giménez-Llort, L., et al. . Physical exercise protects against Alzheimer's disease in 3xTg-AD mice. Journal of Alzheimer's Disease. 2016; 50(4): 785-90.

34. Zhang J, Li, H., & Yabut, O. . Cdk5 inhibitors as potential therapeutic agents for the treatment of Alzheimer's disease. Journal of Medicinal Chemistry. 2020; 63(15): 8178-94.

35. Cho SY, So, W.Y., Roh, H.T. . Resistance training improves cognitive function and decreases tau phosphorylation in APP/PS1 transgenic mice. Experimental Gerontology. 2018; 110(2): 284-91.